Open Orphan 'driving research for novel drug development for rare diseases'
Автор: Proactive Investors
Загружено: 2019-09-16
Просмотров: 791
Описание:
Proactive London sits down with Open Orphan PLC's (LON:ORPH) chief commerical officer Maurice Treacy.
Treacy discusses how he became involved with Open Orphan and his ambitions for the firm's health data initiative.
''Many rare diseases aren't known or badly diagnosed ... but rare isn't rare'', Treacy says.
''Rare is 300 million people in the world, 30 million people in Europe, it's a huge market and untapped to some extent''.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: